from animal experiments,1-4,"2-18 inferences from studies of other vascular regions, primarily the limbs, [19] [20] [21] [22] and a limited number of human studies.5-7 Those human studies were performed using invasive techniques and indicator-dilution methods to assess splanchnic blood flow and/or splanchnic vascular volume (SVV) changes,5-8 but splanchnic vascular volume-pressure (V-P) relations were not determined. Since venous volume (so-called capacitance23) may be altered by having similar variability.38 Radionuclide plethysmography has been used successfully to study the effects of vasoactive drugs38 and mental stress39 on forearm veins. Furthermore, the radionuclide method has been used to assess acute changes in splanchnic vascular V-P relations in animal experiments. 25 Therefore, we designed this study to test the hypothesis that quantitative blood pool scintigraphy can be used to assess human splanchnic venous V-P relations. We used continuous positive airway pressure (CPAP) to alter right atrial pressure, 40 which could passively change splanchnic venous distending pressure and thus, SVV, allowing us to define the splanchnic vascular V-P relation to characterize a given state of venous tone. A secondary goal of this study was to use this method to investigate the effect of nitroglycerin (GTN) on human splanchnic vascular capacitance.
Methods

Patient Population
Patients undergoing diagnostic radionuclide ventriculography were enrolled in the study (groups 1 and 2) if they met the following criteria: 1) apart from atypical chest pain, they had no history of cardiorespiratory symptoms and physical examination was normal; 2) normal ECG; 3) the posttest likelihood of coronary artery disease was <10%41; 4) there was no history or clinical evidence of hypertension, diabetes mellitus, or hepatic or respiratory disease; 5) they were not taking medications except for GTN; 6) they were able to tolerate a CPAP mask comfortably; and 7) they were willing to participate. Patients undergoing cardiac catheterization for the evaluation of chest pain were included in group 3 to assess the hemodynamic effects of CPAP if they had no evidence of heart failure, hypertension, or pulmonary disease, they were willing to participate, and tolerated CPAP breathing. Informed consent was obtained from each patient before participation in this study, which was approved by our institutional ethics committee.
Radionuclide Studies
Radionuclide blood pool imaging was performed after labeling the red blood cells with 9'Tc. Volume-pressure relation. To define the V-P relation of the splanchnic venous bed, 30-second abdominal scintigrams were recorded successively at CPAPs of 0, 5, 8, 10, and 12 cm H20, with stepwise increases at 1-minute intervals; the images were recorded during the second half of each minute. In this way, the regional SVV was measured at each of the above noted CPAPs; these five pairs of data were used to describe the splanchnic venous V-P relation.
A dedicated technician was responsible for adjustment of the CPAP levels and for training the patients before the experiment. Changing the level of CPAP required between 5 and 15 seconds. A second technician was responsible for positioning and control of the gamma camera, activating the automated blood pressure and heart rate recordings, timing each step of the protocol, and coordinating the changes in CPAP with the radionuclide acquisitions.
Effect of nitroglycerin. The effect of GTN on the human splanchnic venous V-P relation was investigated in patients of group 1. Two sets of control data to construct two V-P curves (control 1 and control 2) were obtained 5-8 minutes apart before any intervention, after which patients received 0.6 mg sublingual GTN. Serial abdominal scintigrams at increasing CPAPs, as noted above, were recorded during the control period and 2, 9, and 20 minutes after GTN had dissolved. Thus, we obtained data to plot five splanchnic vascular V-P curves, two controls, and three after GTN. Blood pressure and heart rate were recorded every minute using an automated blood pressure cuff and an ECG, respectively.
Spontaneous variability. The variability of this method to define the splanchnic vascular V-P relation was studied in patients of group 2. Two sets of control data to construct two V-P curves (control 1 and control 2) were obtained 5-8 minutes apart before any intervention, after which patients received a placebo (a small sugar tablet). Abdominal scintigrams were then recorded at increasing CPAPs beginning at 2, 9, and 20 minutes after the placebo had dissolved. Thus, we obtained data to construct five splanchnic vascular V-P curves over a 35-40- There were no significant differences (p>0.5) between the group splanchnic vascular V-P curves recorded during the control stages (control 1 and control 2) in the entire patient population (Figure 1 ) or in the two groups of patients analyzed separately ( Figure 2 ). SPLANCHNIC VASCULAR VOLUME (%) FIGURE 1. Line plot: Group data ofcontrol 1 and control 2 stages of the human splanchnic venous volume-pressure (V-P) relation in the totalpatientpopulation (n=20). Data of splanchnic vascular volume (SVV) are presented as mean +SEM. All SVV measurements were made at the same continuous positive airway pressures (CPAP). Reproducible group V-P curves (p>0.5) were obtained.
Mean differences in regional SVV between the two control curves ranged from 0.4±0.4% (at CPAP of zero) to 1±1.1% (at CPAP of 12 cm H20). The slopes of these two curves were also not significantly different. Individual V-P curves were highly reproducible in most subjects, as depicted in Figure 3 . The SVVs in the two control curves were within 1% in 16 of the 20 patients at zero CPAP and in 10 of the 20 subjects at CPAP of 12 cm H20. Splanchnic vascular volumes remained within 2.0% in all 20 patients at zero CPAP and in 16 of the 20 at CPAP of 12 cm H20. As a result, the two control splanchnic vascular V-P curves were close to each other without significant differences in magnitude or slope (p>0.5).
Average heart rate and systolic and diastolic blood pressures during control 1 were not significantly different from those during control 2 in the entire patient population (66±11 versus 65±10 beats per minute, 122±15 versus 121±14, and 77±11 versus 77±10 mm Hg, respectively, p>0.4) or in groups 1 and 2 when analyzed separately. Furthermore, ANOVA showed no significant effect of CPAP on heart rate or blood pressure. Thus, during the control stages, average heart rates and blood pressures were similar at all CPAPs used (Tables 1 and 2 ).
Effect of Nitroglycerin (Group 1)
Group splanchnic vascular V-P curves before and after administration of GTN are shown in Figure 4 . Compared with control (average of control 1 and control 2), the splanchnic vascular V-P curves at 2-6, 9-13, and 20-24 minutes after GTN were significantly shifted to the right, implying active splanchnic venodilation. Regional SVVs increased at all levels of CPAP by an average of 8.4% (p<0.001), 9.4% (p<0.001), and 5.7% (p<0.01) at 2-6, 9-13, and 20-24 minutes after GTN, respectively, compared with the average volume of the control curve. Analyses of lack of parallelism showed insignificant probability values (p>0.2) between these four V-P curves, implying that the differences in slopes were not statistically significant. As illustrated in Figure 5 , after GTN the splanchnic vascular V-P relation (maximal displacement) shifted to the right in all 12 subjects. Maximal displacement at zero CPAP occurred 2-7 minutes after GTN in five patients and at 9-13 minutes after GTN in seven patients. Compared with control values, regional SVV at CPAP of zero cm H20 increased by >20% in one patient (patient 11), by 10-20% in two patients (patients 2 and 8), by 6-10% in seven patients (patients 3, 4, 5, 6, 7, 9, and 12), and by <6% in the remaining two patients (patients 1 and 10). The slopes of the individual splanchnic vascular V-P curves after GTN administration were similar to those of control in most patients.
After GTN, mean heart rate increased by 14±5 (p<0.001), 10±6 (p<0.001), and 1±4 beats per minute (p>0.2), and group systolic blood pressure decreased by 17±10 (p<0.001), 16±9 (p<0.001), and 8±9 mm Hg (p>0.05) at 2-6, 9-13, and 20-24 minutes after GTN, respectively, compared with control values (Table 1) . Spontaneous Variability (Group 2)
The group splanchnic vascular V-P curves before and after administration of placebo are shown in Figure 6 . Compared with the control curve, the curves at 2-6, 9-13, and 20-24 minutes after placebo were not significantly different in terms of magnitude or slope (p>0.5). Splanchnic vascular volumes at CPAP of zero cm H2O were 100.1%, 100.2%, and 99.2% at 2-6, 9-13, and 20-24 minutes after placebo, respectively, compared with the control value of 100% (p>0.5).
The splanchnic vascular V-P curves before and after administration of placebo were also similar in terms of magnitude and slope in individual patients as shown in Figure 7 (maximal displacement after placebo). Maximal displacement at zero CPAP occurred at 2-6 minutes in one patient, at 9-13 minutes in three patients, SPLANCHNIC VASCULAR VOLUME (%) FIGURE 6. Line plot of repeated measures of the human splanchnic venous volume-pressure (V-P) relation before and after administration of placebo (PLB) in eight stable patients (group 2). No significant differences were noted between the control (C) splanchnic vascular V-P curve (average of control 1 and control 2 data) and those recorded 2-6 minutes (PLB-1), 9-13 minutes (PLB-2), and 20-24 minutes (PLB-3) after sublingual administration of PLB (p>0. 52 The few studies of the human splanchnic veinS5-7, 25, 28, 33, 36, 37 have assessed changes in SVV during acute interventions, but venous V-P relations have never been defined.
The present study describes a method to assess the splanchnic venous V-P relation using blood pool scintigraphy to quantitate changes in SVV. To alter splanchnic venous distending pressure passively, we used low levels of CPAP. CPAP breathing results in increased right atrial pressure directly proportional to the level of CPAP40 caused by elevation of the intrathoracic pressure and thus external constraint, which opposes right atrial filling. Thus, a given level of CPAP decreases the gradient between thoracic and extrathoracic venous pressure and, since splanchnic flow presumably continues, splanchnic venous pressure must increase and cause a degree of passive distension, i.e., a new equilibrium point in the splanchnic venous V-P curve is reached passively. This mechanism is supported by our hemodynamic study (see below). By recording the SVVs at different levels of CPAP, we were able to describe splanchnic vascular V-P curves.
How accurately does quantitative blood pool scintigraphy reflect splanchnic vascular volume? As noted above, blood pool scintigraphy has been shown to accurately reflect regional vascular (venous) volume changes in limbs, 38 and it has been accepted to be a valid measurement of regional intravascular volume changes in liver, lungs, spleen, and kidneys.26-32'36'37 When blood pool scintigraphy is used to measure count-rate changes in an abdominal region away from large vessels (aorta, inferior vena cava, femoral, and iliac veins), liver, spleen, urinary bladder, and kidneys, the count-rate changes reflect changes in intravascular volume of intestines, stomach, and the richly vascularized mesenteric region. This concept has not only been accepted and used to study the effects of exercise and vasoactive drugs in human25'27'28'33'36'37 and animal3'4'18'25'53'54 experiments, but it has been validated in dog experiments in which absolute splanchnic blood volume changes were measured directly and by the radionuclide method in preparations with isolated and controlled perfusion and drainage of the splanchnic vasculature. 4 Bell et al4'36 concluded that blood pool scintigraphy can be used to determine the changes in relative and absolute SVV and have applied this method to study absolute SVV changes in humans. In the present study, we have used the same method as that described by Bell Although the venous V-P relation over a large range of pressures must be curvilinear, recent animal studies have demonstrated linearity over a similar range of pressures as explored here in the splanchnic capacitance vessels.'3'15-'7'25 The present study, which is the first to assess the splanchnic venous V-P relation in humans, showed that the relation was linear in agreediminished cardiac and thoracic blood volumes have in ment with previous animal data presented by Shoukas et al17,65 and Greenway et al. 15 Moreover, the dilatory effect of GTN was shown to take place by a parallel shift of the splanchnic vascular V-P relation resulting from an increased unstressed venous volume similar to that found in the human forearm21,38 and the canine splanchnic veins. 25 
Potential Limitations
The major limitation of this investigation is also what makes it most meritorious. Our results could not be validated by comparing them with other methods because no other method to assess the splanchnic venous V-P relation in humans exists. However, the usefulness of the radionuclide method for assessing regional venous volume changes has been validated in the human forearm38 and the canine splanchnic4 25 and pulmonary66 circulations.
The region of interest used to define the splanchnic region included both anterior and posterior abdominal walls in addition to the target mesenteric and intestinal regions. Preliminary data at our laboratory suggest that this is not a significant problem.67 In dog experiments in which the abdominal walls were isolated, the posterior abdominal wall contributed <2% to total regional counts, and although approximately 25-30% of total counts originated in the ventral abdominal wall, the change in the V-P curves was not significantly different when using total counts or total counts minus counts from the abdominal wall. 67 The SVV changes are expressed as a percentage of baseline values. Using the methods described here, quantitative measures of splanchnic vascular V-P curves can be accurately assessed during acute interventions. However, when studies are performed on different days, absolute volumes are desirable. Bell et al4,66 recently described a method in which radionuclide units were used to estimate absolute volume units using attenuation correction methods. Therefore, slight modifications of the method described here might be used to obtain the human splanchnic vascular V-P relations in absolute volume units, which might then be used during chronic experiments.
Common to most plethysmographic methods used in humans, various levels of CPAP reflect well the directional and quantitative changes in right atrial pressure and probably in large splanchnic veins, but we do not know how well changes in CPAP reflect pressure changes in small splanchnic veins and venules. Concerns that large pressure differences exist between small-and medium-sized veins have not been confirmed in recent studies by Shoukas and Bohlen.17 Insignificant differences were found between distending pressures in first-, second-, and fourth-order intestinal venules in rats.'7 They also found that first-, second-, and fourth-order venules all behaved similarly in response to interventions that produced venoconstriction or venodilation.
We have shown that incremental increases in CPAP produce incremental increases in SVV, presumably by increasing splanchnic venous volume passively as portal pressure increases. However, elevating portal venous pressure may not be the only hemodynamic effect of the relation between changes in splanchnic blood flow and changes in cardiac output is not clear, cardiac output may have decreased minimally in our study, even at pressures of 5 and 8 cm H2O. The effect of any CPAP-induced decrease of splanchnic blood flow on splanchnic venous volume would, however, be opposite to that of the CPAP-induced increase of venous pressure, and the fact that SVV did increase with increasing CPAP indicates that the latter effect predominates. Furthermore, any flow-related effect of CPAP on venous volume can only affect the slope of the V-P relation. We conclude that it is unlikely that flowrelated changes in venous volume might have influenced our observations to any significant degree and thereby undermined the validity of our technique. The effects of CPAP on cardiac output may be different in other clinical settings such as in some patients with heart failure.68 Therefore, it cannot be assumed that this method will also be useful in subjects with heart failure or significant pulmonary or hepatic disease. Summary
The study of the splanchnic veins in humans has remained elusive because of lack of a suitable technique, and until now, the V-P relation of human splanchnic veins has never been recorded. The results of this study showed that quantitative abdominal blood pool scintigraphy and low levels of CPAP can be used to define the human splanchnic venous V-P relation in a reproducible manner. Using this novel method, we have shown that GTN exerted its venodilatory effect by increasing the unstressed splanchnic venous volume. The radionuclide and CPAP method described here appears to be promising for the study of the human splanchnic venous system in health and disease.
